Wcm Investment Management, LLC Kura Oncology, Inc. Transaction History

Wcm Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$29.0 - $41.62 $4.04 Million - $5.8 Million	-139,462 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$16.3 - $30.64 $139,593 - $262,400	8,564 Added 6.54%	139,462 $4.27 Million
Q2 2020 Aug 18, 2020	SELL	$7.95 - $18.81 $824,112 - $1.95 Million	-103,662 Reduced 44.19%	130,898 $2.13 Million
Q1 2020 May 08, 2020	BUY	$6.45 - $14.04 $437,219 - $951,715	67,786 Added 40.65%	234,560 $2.33 Million
Q4 2019 Feb 07, 2020	BUY	$12.97 - $15.94 $1.92 Million - $2.36 Million	147,780 Added 778.04%	166,774 $2.29 Million
Q2 2019 Aug 06, 2019	SELL	$14.71 - $19.79 $4,324 - $5,818	-294 Reduced 1.52%	18,994 $374,000
Q1 2019 May 13, 2019	BUY	$13.73 - $16.87 $264,824 - $325,388	19,288 New	19,288 $320,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $490M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Wcm Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wcm Investment Management, LLC with notifications on news.